Differential roles of galanin on mechanical and cooling responses at the primary afferent nociceptor

  • Richard P Hulse1, 2,

    Affiliated with

    • Lucy F Donaldson1Email author and

      Affiliated with

      • David Wynick1, 2

        Affiliated with

        Molecular Pain20128:41

        DOI: 10.1186/1744-8069-8-41

        Received: 21 January 2012

        Accepted: 6 June 2012

        Published: 6 June 2012

        Abstract

        Background

        Galanin is expressed in a small percentage of intact small diameter sensory neurons of the dorsal root ganglia and in the afferent terminals of the superficial lamina of the dorsal horn of the spinal cord. The neuropeptide modulates nociception demonstrating dose-dependent pro- and anti-nociceptive actions in the naïve animal. Galanin also plays an important role in chronic pain, with the anti-nociceptive actions enhanced in rodent neuropathic pain models. In this study we compared the role played by galanin and its receptors in mechanical and cold allodynia by identifying individual rat C-fibre nociceptors and characterising their responses to mechanical or acetone stimulation.

        Results

        Mechanically evoked responses in C-fibre nociceptors from naive rats were sensitised after close intra-arterial infusion of galanin or Gal2-11 (a galanin receptor-2/3 agonist) confirming previous data that galanin modulates nociception via activation of GalR2. In contrast, the same dose and route of administration of galanin, but not Gal2-11, inhibited acetone and menthol cooling evoked responses, demonstrating that this inhibitory mechanism is not mediated by activation of GalR2. We then used the partial saphenous nerve ligation injury model of neuropathic pain (PSNI) and the complete Freund’s adjuvant model of inflammation in the rat and demonstrated that close intra-arterial infusion of galanin, but not Gal2-11, reduced cooling evoked nociceptor activity and cooling allodynia in both paradigms, whilst galanin and Gal2-11 both decreased mechanical activation thresholds. A previously described transgenic mouse line which inducibly over-expresses galanin (Gal-OE) after nerve injury was then used to investigate whether manipulating the levels of endogenous galanin also modulates cooling evoked nociceptive behaviours after PSNI. Acetone withdrawal behaviours in naive mice showed no differences between Gal-OE and wildtype (WT) mice. 7-days after PSNI Gal-OE mice demonstrated a significant reduction in the duration of acetone-induced nociceptive behaviours compared to WT mice.

        Conclusions

        These data identify a novel galaninergic mechanism that inhibits cooling evoked neuronal activity and nociceptive behaviours via a putative GalR1 mode of action that would also be consistent with a TRP channel-dependent mechanism.

        Keywords

        Galanin Primary afferent Cold Neuropathic pain Inflammatory pain

        Background

        Galanin is expressed at low levels in less than 5% of adult rodent dorsal root ganglia (DRG) neurons; those expressing galanin are predominantly small diameter C-fibre nociceptors. Higher levels of the neuropeptide are expressed in the primary afferent terminals in the superficial layers of the dorsal horn in naïve animals [1]. Levels of galanin in the rodent, primate and human DRG markedly rise after peripheral nerve injury [1, 2]. Administration of galanin to either the peripheral [3] or central [4] nervous systems results in a significant alteration in mechanosensory nociceptive behaviours. These actions are dose-dependent with facilitation occurring at low concentrations and inhibition at higher concentrations [3, 4]. After nerve injury, when a subset of mechano-nociceptors are sensitised to mechanical stimulation [5] and the endogenous levels of galanin in the DRG are high, there is good agreement in the literature that the anti-nociceptive actions of galanin are enhanced in rodent models of neuropathic pain [6]. In contrast to the extensive dataset on galanin modulation of mechanosensory behaviours, there have been few studies on galanin and cold behaviours. Work to date has shown that in the naïve uninjured animal intrathecal infusion of low dose galanin facilitates cold nociceptive behavioural responses [7]. In contrast, in a model of neuropathic pain galanin is anti-nociceptive, attenuating cold pain [8].

        The nociceptive effects of galanin are mediated by the activation of one or more of three G-protein coupled galanin receptor subtypes, designated GalR1, GalR2 and GalR3. Studies using in-situ hybridization have shown that GalR1 and GalR2 mRNAs are expressed by 51% and 83% of adult rat DRG neurons respectively [9], and the levels of both sub-types decrease after nerve injury [10, 11]. In contrast, no change in the expression of either subtype was observed in the dorsal horn of the spinal cord after axotomy [12]. Expression of GalR3 in the spinal cord and DRG in both rat and mouse is very low as determined by RT-70 PCR [13, 14], and in situ hybridization [15]. We and others have shown that the central and peripheral anti-nociceptive effects of galanin on mechanosensory thresholds are principally mediated by activation of GalR1 [7] and GalR2 [3], respectively. Only two papers have studied which of the galanin receptors mediate the effects of galanin on cold nociception. Liu et al. showed that intrathecal infusion of low dose Gal2-11 (a GalR2/3-specific agonist) increased nociceptive responses to acetone in the naive rat, similar to that seen with galanin [7]. In contrast, Blakeman et al. demonstrated an increase in cold pain scores in naive GalR1-KO mice compared to strain-matched wild-type (WT) controls [16].

        Here we investigated the role that galanin and its receptors play at the primary afferent with particular reference to cold sensitivity, demonstrating that close intra-arterial administration of galanin inhibits C-fibre nociceptor cooling activity in normal, nerve-injured and inflamed animals. These actions appear to be independent of GalR2 activation. These data identify a novel galaninergic mechanism that inhibits cooling-evoked neuronal activity and nociceptive behaviours consistent with a TRP channel-dependent mechanism.

        Results

        Using multi-unit recordings in naive rats and models of neuropathic and inflammatory pain, we studied the differential effects of galanin and the GalR2/3-specific agonist Gal2-11 on primary afferent nociceptor activities to mechanical and cooling stimulation.

        Differential effects of galanin and Gal2-11 on naïve primary afferent nociceptor activities to mechanical and cooling stimulation

        Galanin 100 μM was administered via c.i.a. (close intra-arterial) as previously described [17]. Mechanical activation thresholds were significantly reduced following galanin administration (Figure 1A, ***p < 0.001) and mechanically evoked activity was enhanced (Figure 1B, ** p < 0.01). Similarly, c.i.a. administration of 100 μM Gal2-11 led to a significant reduction in activation thresholds of mechanically sensitive C-fibre afferents (Figure 1C, **p < 0.01) and an increase in mechanically evoked activity (Figure 1D, *p < 0.05).
        http://static-content.springer.com/image/art%3A10.1186%2F1744-8069-8-41/MediaObjects/12990_2012_Article_487_Fig1_HTML.jpg
        Figure 1

        Facilitatory actions of galanin via activation of GalR2 on mechano-nociceptor afferents [A] Mechanical activation thresholds were reduced by c.i.a 100 μM galanin in naïve rats (*** p < 0.001 Mann Whitney test, n = 24) and [B] mechanically evoked activity was increased by c.i.a 100 μM galanin in response to a 10 g vF hair mechanical stimulus (**p < 0.01 paired t-test). [C] Mechanical activation thresholds were reduced following c.i.a 100 μM Gal2-11 administration (** p < 0.01 Mann Whitney test, n = 14) and [D] mechanically evoked activity was increased by c.i.a 100 μM Gal2-11 in response to a 10 g vF hair mechanical stimulus (* p < 0.01 paired t-test, n = 14).

        Application of acetone, which leads to mild nociceptive behaviours in naïve rodents [18], reduced skin temperature for approximately 30–60 seconds by ~5°C from a resting temperature of ~25°C (Figure 2A). Room temperature saline was used to confirm that the mechanical application of a drop of fluid to the receptive field did not alter skin temperature (Figure 2A) or neuronal responses (Figure 2B). On-going neuronal activity in cooling primary afferents (as previously described [19]), was identified from the application of room temperature saline (Figures 2B and 3A). All cooling sensitive afferents had CVs less than 1 m/s and were thus classified as cooling sensitive C-fibres. Application of acetone to the receptive field significantly increased afferent evoked activity compared to room temperature saline (Figures 2B & 3A *p < 0.05, **p < 0.01 one way ANOVA). Acetone responses following c.i.a. 100 μM galanin were significantly reduced (Figures 2B & 2D, * p < 0.05 Paired t-test). In contrast, 100 μM Gal2-11 had no effect on acetone evoked responses (Figures 3A and 3C).
        http://static-content.springer.com/image/art%3A10.1186%2F1744-8069-8-41/MediaObjects/12990_2012_Article_487_Fig2_HTML.jpg
        Figure 2

        Exogenous galanin attenuates cooling responses. [A] Digitised trace of recording of subcutaneous skin temperature of the dorsal surface of the rat hindpaw. Room temperature saline did not alter skin temperature. Application of acetone led to a reduction in skin temperature. This returned to normal within 100 seconds. A second application of acetone again resulted in a similar drop in temperature. [B] Acetone application to the receptive field of an identified cooling sensitive primary afferent led to a significant increase in neuronal firing, which was significantly greater than the control application of room temperature saline (**p < 0.01 one way ANOVA with post-hoc Bonferroni test, n = 6). Cooling evoked activity was significantly inhibited following administration of c.i.a. 100 μM galanin (*p < 0.05 Paired t-test, n = 6). [C] Example trace of an acetone/cooling sensitive C fibre in response to room temperature saline. [D] Example trace of an acetone/cooling sensitive C fibre. [E] Acetone evoked activity was attenuated in the same C fibre by c.i.a. 100 μM galanin. AP = action potential, AP number events = total number of action potentials occurring per second.

        http://static-content.springer.com/image/art%3A10.1186%2F1744-8069-8-41/MediaObjects/12990_2012_Article_487_Fig3_HTML.jpg
        Figure 3

        Acetone evoked activity is not inhibited by GalR2/3 activation. [A] c.i.a. 100 μM Gal2-11 did not alter acetone-induced cooling responses (n = 6). [B] Example trace of an acetone/cooling sensitive C fibre. [C] The acetone evoked activity was not altered by Gal2-11. AP = action potential, AP number events = total number of action potentials occurring per second.

        We then investigated the effects of galanin and Gal2-11 on the neuronal activity elicited after application of the cooling agent menthol; an activator of the cold sensitive channel TRPM8 [20]. Menthol evoked action potentials in 8 out of 10 acetone/cooling sensitive afferents. A single c.i.a bolus dose of 100 mM menthol led to a robust increase in evoked activity (Figure 4A) which was significantly reduced when preceded by c.i.a administration of 100 μM galanin (Figure 4B, *p < 0.05 one way ANOVA) but not by c.i.a 100 μM Gal2-11 (Figure 4B).
        http://static-content.springer.com/image/art%3A10.1186%2F1744-8069-8-41/MediaObjects/12990_2012_Article_487_Fig4_HTML.jpg
        Figure 4

        Menthol evoked activity is not inhibited by GalR2/3 activation. [A] The concentration response relationship demonstrates that acetone sensitive C fibres responds only to c.i.a. 100 mM menthol (***p < 0.001, one way ANOVA with post-hoc Bonferroni test, n = 4). [B] Menthol evoked activity was reduced by c.i.a. 100 μM galanin but not by c.i.a. 100 μM Gal2-11 (* p < 0.05, one way ANOVA with post-hoc Bonferroni test, n = 7).

        Differential effects of galanin and Gal2-11 on primary afferent nociceptor activities to mechanical and cooling stimulation in chronic pain models

        In rats that had undergone PSNI that results in mechanical and cold allodynia, c.i.a. 100 μM galanin and c.i.a 100 μM Gal2-11 both led to a significant reduction in mechanical activation thresholds of C-fibres (Figure 5A, ***p < 0.001). In contrast, acetone-evoked activity in C-fibre afferents was significantly attenuated following c.i.a 100 μM galanin (Figure 5B, *p < 0.05, ***p < 0.001) but not by c.i.a 100 μM Gal2-11 (Figure 5B).
        http://static-content.springer.com/image/art%3A10.1186%2F1744-8069-8-41/MediaObjects/12990_2012_Article_487_Fig5_HTML.jpg
        Figure 5

        Differential role of galanin in a model of neuropathic pain [A] Exogenous c.i.a 100 μM galanin and c.i.a 100 μM Gal2-11 both facilitated mechano-nociceptor responses in the partial saphenous nerve injury model of neuropathic pain (** p < 0.01, *** p < 0.001, Kruskal Wallis test with Dunn’s multiple comparison test, galanin n = 15, Gal2-11 n = 6). [B] In the PSNI neuropathic pain model acetone application to the receptive field of cold sensitive C fibres led to a significant increase in evoked activity (***p < 0.001, Kruskal-Wallis with Dunn’s multiple comparison test). Acetone-induced evoked activity was inhibited by c.i.a 100 μM galanin but was not altered by c.i.a 100 μM Gal2-11 (***p < 0.001, one way ANOVA with post-hoc Bonferroni test, n = 10) [C] Acetone-induced withdrawal behaviours in naïve Gal-OE transgenic mice did not differ from WT controls. 7-days after nerve injury the Gal-OE mice demonstrated a significant reduction in cooling pain like behaviours compared to matched WT mice (*p < 0.01, two way ANOVA with post-hoc Bonferroni test, n = 7).

        A previously described transgenic mouse line which inducibly over-expresses galanin (Gal-OE) after nerve injury [21] was used to investigate whether manipulating the levels of endogenous galanin also modulates cooling evoked nociceptive behaviours after PSNI. We have previously shown a marked attenuation of mechanical allodynia in these mice after PSNI [3, 21]. Acetone withdrawal behaviours in naive mice showed no differences between Gal-OE and WT mice. 7-days after PSNI Gal-OE mice demonstrated a significant reduction in the duration of acetone-induced nociceptive behaviours compared to WT mice (Figure 5C, *p < 0.01 two way ANOVA).

        Similar responses were also observed following CFA treatment in the rat. The degree of inflammation at 5 days was confirmed by measuring ankle joint swelling (Figure 6A, ***p < 0.001, paired t-test). 100 μM galanin and 100 μM Gal2-11 by c.i.a administration both led to a significant reduction in mechanical activation thresholds of mechanically sensitive C-fibres (Figure 6B, **p < 0.01, ***p < 0.001). In contrast, c.i.a 100 μM galanin, but not c.i.a 100 μM Gal2-11, attenuated the acetone evoked responses in cooling sensitive C-fibres (Figure 6C, *p < 0.05 one way ANOVA).
        http://static-content.springer.com/image/art%3A10.1186%2F1744-8069-8-41/MediaObjects/12990_2012_Article_487_Fig6_HTML.jpg
        Figure 6

        Differential role of galanin in CFA inflammation [A] CFA inflammation was confirmed through significant ipsilateral ankle joint swelling compared to the contralateral joint (***p < 0.001, paired t-test, n = 6). [B] Exogenous c.i.a. 100 μM galanin and c.i.a. 100 μM Gal2-11 both significantly facilitated mechano-nociceptor mechanical responses in CFA inflamed rats (** p < 0.01, *** p < 0.001, Kruskal-Wallis with Dunns multiple comparison test, n = 9). [C] Exogenous c.i.a. 100 μM galanin, but not c.i.a. 100 μM Gal2-11, reduced acetone evoked activity (* p < 0.05, one way ANOVA with post-hoc Bonferroni, n = 6).

        Discussion

        This study describes the differential roles played by galanin in the peripheral nervous system with respect to mechanical- and cold-pain behaviours in the naive state and following models of neuropathic and inflammatory pain. Here we show opposing actions of galanin, with inhibition of cold- and facilitation of mechanical-responses, in C-fibre nociceptors.

        Cold allodynia (the sensation of pain to a normally innocuous stimulus) is a common complaint of patients with neuropathic pain, irrespective of the underlying cause [2224] and similar findings are found in a range of rodent models of neuropathic and inflammatory pain behaviours following stimulation with acetone or menthol [2528]. Cooling detection in humans is highly variable. It occurs after a drop in temperature of only a few degrees [29, 30] and is highly correlated with the activation temperature of TRPM8 [3133] (31-27°C). Cold pain thresholds are also highly variable, but are usually reported at lower temperatures [31, 34] (<10°C). Patients with neuropathic pain report pain after only a small reduction in skin temperature with thresholds reported to be >20°C [35]. At these temperatures, symptoms are described as painful with intense pain occurring at lower temperatures [23] (~15°C). Recent work has made considerable progress in defining the molecular transducers of cutaneous thermo-sensation and the mechanisms that underlie cold allodynia. A number of thermal sensors have been identified which all belong to the Transient Receptor Potential (TRP) ion channel family. The best characterised cold receptor is TRPM8 [3638]. TRPA1 was proposed as a noxious cold sensor but more recent evidence has disputed a specific contribution for TRPA1 in cold transduction [28, 39, 40]. TRPM8 is expressed by a subpopulation of small diameter C-fibre neurons [41]. TRPM8 responds to cooling agents such as acetone with an activation temperature threshold of ~26°C, with activity increasing in magnitude down to 8°C [36, 38]. Menthol activates TRPM8 [42] and does not influence TRPA1 activity in non-human mammals [20, 43, 44]. Consistent with these findings, behavioural nociceptive responses over a range of innocuous and noxious temperatures and to the application of menthol are attenuated in TRPM8-KO mice, whereas these responses remain intact in the TRPA1-KO [39].

        In the present study we have shown that galanin, but not Gal2-11, inhibits acetone and menthol responses in the naive rodent and following models of neuropathic and inflammatory pain. Similarly, overexpression of galanin after nerve injury in the DRG of Gal-OE mice led to the inhibition of cooling pain responses compared to those of wild type mice, confirming that high levels of endogenous galanin also inhibit cooling behaviours. The modulatory effects of galanin on cooling are independent of GalR2 and GalR3 activation since Gal2-11, which is equally selective for GalR2 and GalR3 [45], does not inhibit cooling pain behaviours. Further, since GalR3 is expressed at very low levels in the primary nociceptor in the intact and injured state [14], these findings imply the effects of galanin on cold responses are mediated by activation of GalR1. These findings are consistent with our work on the Gal-KO [46] and that of Blakeman et al. which demonstrate an increase in cold pain scores in naive GalR1-KO mice compared to strain-matched wild-type (WT) controls [16].

        Since galanin suppresses the effects of acetone and menthol and the majority of acetone-sensitive C-fibres were also activated by c.i.a administration of menthol, this implies a mechanism via the modulation of the TRPM8 cold sensor. To date, no publication has investigated the effects of galanin and its receptors on TRPM8 activity. However, peripheral administration of galanin has been shown to modulate TRPV1 (Transient Receptor Potential Vanilloid) activity following inflammation, as GalR1-activation inhibits capsaicin-evoked pain behaviours [47], whilst GalR2-activation facilitates the same nociceptive responses [48]. Of note, all three galanin receptors couple to Gi/o and inhibit adenylyl cyclase [49, 50], whilst GalR2 also signals via Gq/11 to activate phospholipase C (PLC) and protein kinase C (PKC) [51]. Previous work has shown that TRPM8 activity in the DRG is inhibited by the Gi/o adenylyl cyclase pathway [52], which is again consistent with a GalR1-dependent modulation of the channel.

        In contrast to the above inhibitory effects of peripheral administration of galanin on cooling nociception, here we show that c.i.a administration of the same dose (100 μM) of galanin and Gal2-11 both facilitate mechano-sensory responses. The nature and magnitude of these changes (Figure 1) are very similar to our previously published dataset using injection of 100nM galanin or 100nM Gal2-11 directly into the afferent receptive field in naïve adult male rats [3] (Figures 1 5A and 6B in that paper). This implies that the local concentration of galanin or Gal2-11 at the nociceptor is ~1000-fold lower than that administered by c.i.a bolus injection which may be explained by a combination of dilution of the peptides by the blood volume of the hind limb and only partial tissue penetration of the peptides. Our current and previous findings confirm that the peripheral mechano-nociceptive effects of galanin appear to be predominantly dependent on activation of GalR2, in contrast to the effects of galanin administered intrathecally which appear to be mediated by activation of GalR1 [7].

        In conclusion, peripheral administration of galanin, but not Gal2-11, inhibits acetone- and menthol-evoked activity in C-fibre nociceptors in the normal animal and in models of neuropathic and inflammatory pain. These data identify a novel putative GalR1-dependent pathway that inhibits cooling-evoked neuronal activity and nociceptive behaviours, consistent with a TRPM8-dependent mechanism. Taken together with the known peripheral GalR2-dependent modulation of mechano-nociception, these findings imply that activation of peripheral GalR1 and GalR2 will both be important to treat cold and mechanical allodynia that occurs in various neuropathic pain conditions.

        Materials and methods

        Animals

        Experiments were performed on adult male Wistar rats (250 g-350 g) and mice (~25 g). 47 Wistar rats were used for electrophysiological experiments. 10 transgenic mice that inducibly over-express galanin in the DRG as previously described [3], and 10 matched WT controls were used in nociceptive behavioural testing. Animals were fed standard chow and water ad libitum and all experiments were carried out in accordance with the United Kingdom Animals (Scientific Procedures) Act 1986.

        Electrophysiological recordings

        Anaesthesia was induced using sodium pentobarbital (60 mg/kg i.p. rats, Sigma-Aldrich, UK) and were maintained deeply anaesthetised and areflexive for the duration of the experiment (~20 mg/kg/hr, sodium pentobarbital delivered intravenously via cannulation of the external jugular vein). A tracheotomy was performed to maintain the airway. Monitoring of blood pressure was carried out via a femoral artery cannulation of the left hind limb. Rodent body temperature was maintained at ~37.5°C by means of a feedback controlled heater and rectal thermistor. At the end of all experiments, rats were overdosed with a single large bolus of (60 mg/ml) sodium pentobarbital.

        An incision was made along the inguinal fossa of the right hind leg to expose the saphenous nerve which runs superficially under the skin adjacent to the femoral vasculature. Using blunt dissection, connective tissue was removed and the skin was freed. Using the skin a pool was formed by attaching the skin to a metal pool ring, which was filled with warmed mineral oil (Sigma-Aldrich, UK). Fine forceps were used to dissect out a sufficient length of the nerve that was placed onto a dental mirror. The main saphenous nerve trunk was further prepared by removing the surrounding epineurium. Fine filaments were dissected out and cut proximally. These nerve filaments were placed onto bipolar platinum recording electrodes to record from individual afferent responses. Identified fine nerve filaments were ensured to have a low number of responsive receptive fields in the hindpaw (<3), with these receptive fields not overlapping. The neuronal activity of individual afferents was captured and spike sorted offline using micro1401 and Spike2 software (C.E.D. Cambridge, UK).

        Afferent characterisation

        Primary afferents were identified using search stimuli of both blunt/pinch mechanical stimulation of the medial surface of the hindpaw, and electrical stimulation. Each afferent identified was characterised with the same protocol as described below. Upon identification of a receptive field the conduction velocity (CV) for the afferent was recorded. Electrical stimulation of the receptive field (0.5 ms stimulus duration, up to 100 V, every 3 seconds) was used to calculate the conduction velocity of the afferent. Three or more robust CVs from the receptive field were required to confirm reproducibility and confirmation of afferent excitation. CVs less than 1 m/s were classed as C fibres, those with greater than 1 m/s as A fibres [53]. On-going neuronal activity was monitored for 100 seconds following CV characterisation. This 100 second period recorded any neuronal activity from the afferent that occurred without any stimulus being applied to the receptive field. Mechanical responses were recorded using calibrated plastic filaments; von Frey hairs (Linton Instruments, UK) and brush stimulation. Von Frey hairs (vF) were used to elicit mechanical responses, with each vF hair applied three times for a maximum of five seconds. The mechanical activation threshold was determined using an adapted up and down method, and the lowest vF hair that elicited a robust response (response >3 action potentials) was noted as the activation threshold [54]. Afferents were also tested for innocuous cooling responses. Acetone was applied to the receptive field to test for cooling responses. This stimulus leads to withdrawal behaviours [55] and is a standard tool to excite cooling neuronal responses [56, 57]. Prior to acetone, a single drop of room temperature saline was applied (using a Gilson and 1 ml pipette tip) to the receptive field to identify any mechanical response occurring due to the application of a drop of fluid. Neuronal activity was recorded for 30 seconds post stimulation. Room temperature saline and acetone were each applied a total of 3 times with 5 minutes between each application to allow skin temperature and neuronal activity to recover to baseline levels. Mean acetone and saline evoked responses were calculated. To note, cooling afferent groups studied with drug administration include both CCs (cold sensitive C fibres) and CMCs (mechano-cold sensitive C fibres) as previously described [58, 59]. Drug responses were not different between these two groups.

        Experimental protocol and drug administration

        Following baseline mechanical and cooling characterisation of primary afferent fibres, drugs were administered via the close intra-arterial (c.i.a) route as previously described [17, 60]. The left femoral artery was cannulated in the groin and the cannula was advanced proximally, approximately ~2.5 cm, towards the bifurcation of the descending aorta. Cannula positioning was confirmed by visual inspection upon termination of experiment. Menthol (Sigma-Aldrich), 100 μM galanin (Bachem) or 100 μM Gal2-11 (Sigma-Aldrich, UK), were made up in saline and injected and washed through the c.i.a. cannula with 400ul of saline (containing heparin 50units/ml). 5 minutes after galanin or Gal2-11 injection either mechanical, acetone and menthol responses were tested. Since galanin and Gal2-11 have short half-life of <10 minutes [46, 61], in some experiments galanin and Gal2-11 were tested sequentially in the same animal to reduce the number of animals used. 30 minutes was allowed between peptides to allow for metabolism and removal. 100 mM menthol (Sigma-Aldrich, UK) was administered via c.i.a cannula as previously described [28, 55, 60]. Menthol was dissolved in 10% ethanol, 10% Tween80 and 80% saline and vehicle alone had no effect on neuronal activity (data not shown).

        Temperature recordings

        A thermocouple was advanced under the skin of the medial surface of the hindpaw using a 25-gauge needle. The thermocouple was used to identify changes in skin temperature following application of various stimuli. Saline and acetone were applied and temperature changes monitored and recorded using a CED micro 1401 and Spike2 software as described previously [56].

        Chronic pain models

        For all recovery surgeries; partial saphenous nerve ligation injury (PSNI) and complete Freund’s adjuvant (CFA), anaesthesia was induced using 4% halothane in oxygen and maintained with 2-3% for all procedures.

        PSNI surgery

        The PSNI surgery was performed as previously described [57, 62] on 19 male wistar rats and 20 male mice, leading to the characteristic neuropathic pain phenotypes of mechanical allodynia and cooling allodynia [57, 62, 63]. An incision was made along the inguinal fossa of the right hind leg and the saphenous nerve was isolated using blunt dissection. A sterile silk suture (mouse: 7.0 suture and rat: 4.0 suture) was used to tightly ligate 50% of the saphenous nerve. The skin incision was closed using size 4.0 sutures. The animals were allowed to recover and monitored for the duration of the experiment. Electrophysiological experimentation was performed 7 days after PSNI surgery.

        Complete freunds adjuvant (CFA) inflammation

        Two 50 μl injections of CFA (1 mg/ml, Sigma-Aldrich, UK), one on either side of the tibio-tarsal ankle joint, were used to induce inflammation in nine male Wistar rats as previously described [60] for electrophysiological experimentation and left to develop for five days. This intervention leads to significant swelling of the ankle and hindpaw [64].

        Animal behaviour

        Mice were habituated to behavioural testing enclosures (mesh floored holding chambers) the day prior to testing for 15 minutes. For testing days animals were placed into behavioural enclosures 10 minutes prior to testing. Using a 1 ml syringe, acetone was applied to the plantar surface of the hindpaw. The duration of flinching/pain like behaviour (seconds) was recorded immediately following acetone application for a total period of five minutes. This was performed three times for each hindpaw, from which the mean was calculated. Stimulations of the right and left hindpaw were alternated to prevent sensitisation and allow recovery of skin temperature. Baselines were taken for two separate recording sessions and were then used to generate the baseline timepoint. Seven days post nerve injury animals were re-tested for acetone responses.

        Statistical analysis

        Paired t-test and one way ANOVA with post-hoc Bonferroni tests were used to determine primary afferent evoked activity to mechanical or cooling stimulation before and after drug, as appropriate (galanin, Gal2-11 and menthol, *p < 0.05, **p < 0.01, ***p < 0.001). Mechanical activation threshold was determined by Mann Whitney Test or Kruskal-Wallis test with Dunns multiple comparison test (*p < 0.05, **p < 0.01, ***p < 0.001). To determine if galanin or Gal2-11 facilitated mechanical responses (increased number of action potentials) to an evoked stimulus, a cut off was set as two standard deviations above and below the mean of the evoked activity. In addition, cooling sensitive primary afferent evoked activity in response to acetone was calculated through a fold change in activity compared to that following room temperature saline application. Percentage change of cold induced pain like behavioural responses following PSNI were calculated from baseline naïve animal responses. Two way ANOVA with post bonferroni tests was used to determine differences in the Gal-OE cooling behaviour analysis. All data are presented as mean ± SEM.

        Abbreviations

        CFA: 

        Complete Freunds adjuvant

        c.i.a: 

        Close intra arterial

        DRG: 

        Dorsal root ganglia

        Gal: 

        Galanin

        GalR: 

        Galanin receptor

        Gal-OE: 

        Galanin over-expressing transgenic mice

        i.t: 

        Intrathecal

        KO: 

        Knockout

        PSNI: 

        Partial saphenous nerve injury

        WT: 

        Wild-type mice.

        Declarations

        Acknowledgements

        Work was supported by the Medical Research Council, The Wellcome Trust and National Institute on Aging (AG10668). We also thank Prof Bruce Matthews for his invaluable advice and assistance.

        Authors’ Affiliations

        (1)
        School of Physiology and Pharmacology, University of Bristol, University Walk
        (2)
        School of Clinical Sciences, University Walk

        References

        1. Villar MJ, Cortes R, Theodorsson E, Wiesenfeld HZ, Schalling M, Fahrenkrug J, Emson PC, Hokfelt T: Neuropeptide expression in rat dorsal root ganglion cells and spinal cord after peripheral nerve injury with special reference to galanin. Neuroscience 1989, 33: 587–604. 10.1016/0306-4522(89)90411-9View ArticlePubMed
        2. Hokfelt T, Wiesenfeld HZ, Villar M, Melander T: Increase of galanin-like immunoreactivity in rat dorsal root ganglion cells after peripheral axotomy. Neurosci Lett 1987, 83: 217–220. 10.1016/0304-3940(87)90088-7View ArticlePubMed
        3. Hulse R, Wynick D, Donaldson LF: Activation of the galanin receptor 2 in the periphery reverses nerve injury-induced allodynia. Mol Pain 2011, 7: 26. 10.1186/1744-8069-7-26PubMed CentralView ArticlePubMed
        4. Wiesenfeld-Hallin Z, Villar MJ, Hokfelt T: The effects of intrathecal galanin and C-fiber stimulation on the flexor reflex in the rat. Brain Res 1989, 486: 205–213. 10.1016/0006-8993(89)90506-4View ArticlePubMed
        5. Hulse RP, Donaldson LF, Wynick D: Peripheral galanin receptor 2 as a target for the modulation of pain. Pain Res Treat 2012, 2012: 545386.PubMed CentralPubMed
        6. Wiesenfeld HZ, Xu XJ, Langel U, Bedecs K, Hokfelt T, Bartfai T: Galanin-mediated control of pain: enhanced role after nerve injury. Proc Natl Acad Sci USA 1992, 89: 3334–3337. 10.1073/pnas.89.8.3334View Article
        7. Liu HX, Brumovsky P, Schmidt R, Brown W, Payza K, Hodzic L, Pou C, Godbout C, Hokfelt T: Receptor subtype-specific pronociceptive and analgesic actions of galanin in the spinal cord: Selective actions via GalR1 and GalR2 receptors. Proc Natl Acad Sci USA 2001, 98: 9960–9964. 10.1073/pnas.161293598PubMed CentralView ArticlePubMed
        8. Hao JX, Shi TJ, Xu IS, Kaupilla T, Xu XJ, Hokfelt T, Bartfai T, Wiesenfeld HZ: Intrathecal galanin alleviates allodynia-like behaviour in rats after partial peripheral nerve injury. European Journal Of Neuroscience 1999, 11: 427–432. 10.1046/j.1460-9568.1999.00447.xView ArticlePubMed
        9. Kerekes N, Mennicken F, O'Donnell D, Hokfelt T, Hill RH: Galanin increases membrane excitability and enhances Ca(2+) currents in adult, acutely dissociated dorsal root ganglion neurons. Eur J Neurosci 2003,18(11):2957–2966. 10.1111/j.1460-9568.2003.03057.xView ArticlePubMed
        10. Sten Shi TJ, Zhang X, Holmberg K, Xu ZQ, Hokfelt T: Expression and regulation of galanin-R2 receptors in rat primary sensory neurons: effect of axotomy and inflammation. Neurosci Lett 1997, 237: 57–60. 10.1016/S0304-3940(97)00805-7View ArticlePubMed
        11. Xu ZQ, Shi TJ, Landry M, Hokfelt T: Evidence for galanin receptors in primary sensory neurones and effect of axotomy and inflammation. Neuroreport 1996, 8: 237–242. 10.1097/00001756-199612200-00048View ArticlePubMed
        12. Brumovsky P, Mennicken F, O'Donnell D, Hokfelt T: Differential distribution and regulation of galanin receptors- 1 and −2 in the rat lumbar spinal cord. Brain Res 2006, 1085: 111–120. 10.1016/j.brainres.2006.02.088View ArticlePubMed
        13. Waters SM, Krause JE: Distribution of galanin-1, -2 and −3 receptor messenger RNAs in central and peripheral rat tissues. Neuroscience 2000, 95: 265–271.View ArticlePubMed
        14. Hobson SA, Holmes FE, Kerr NCH, Pope RJ, Wynick D: Mice deficient for galanin receptor 2 have decreased neurite outgrowth from adult sensory neurons and impaired pain-like behaviour. J Neurochem 2006, 99: 1000–1010. 10.1111/j.1471-4159.2006.04143.xPubMed CentralView ArticlePubMed
        15. Mennicken F, Hoffert C, Pelletier M, Ahmad S, O'Donnell D: Restricted distribution of galanin receptor 3 (GalR3) mRNA in the adult rat central nervous system. J Chem Neuroanat 2002, 24: 257–268. 10.1016/S0891-0618(02)00068-6View ArticlePubMed
        16. Blakeman KH, Hao JX, Xu XJ, Jacoby AS, Shine J, Crawley JN, Iismaa T, Wiesenfeld-Hallin Z: Hyperalgesia and increased neuropathic pain-like response in mice lacking galanin receptor 1 receptors. Neuroscience 2003, 117: 221–227. 10.1016/S0306-4522(02)00779-0View ArticlePubMed
        17. Heppelmann B, Just S, Pawlak M: Galanin influences the mechanosensitivity of sensory endings in the rat knee joint. European Journal Of Neuroscience 2000, 12: 1567–1572. 10.1046/j.1460-9568.2000.00045.xView ArticlePubMed
        18. Ji G, Zhou S, Carlton SM: Intact Adelta-fibers up-regulate transient receptor potential A1 and contribute to cold hypersensitivity in neuropathic rats. Neuroscience 2008, 154: 1054–1066. 10.1016/j.neuroscience.2008.04.039PubMed CentralView ArticlePubMed
        19. Leem JW, Willis WD, Chung JM: Cutaneous sensory receptors in the rat foot. J Neurophysiol 1993, 69: 1684–1699.PubMed
        20. Xiao B, Dubin AE, Bursulaya B, Viswanath V, Jegla TJ, Patapoutian A: Identification of transmembrane domain 5 as a critical molecular determinant of menthol sensitivity in mammalian TRPA1 channels. J Neurosci 2008, 28: 9640–9651. 10.1523/JNEUROSCI.2772-08.2008PubMed CentralView ArticlePubMed
        21. Holmes FE, Bacon A, Pope RJ, Vanderplank PA, Kerr NC, Sukumaran M, Pachnis V, Wynick D: Transgenic overexpression of galanin in the dorsal root ganglia modulates pain-related behavior. Proc Natl Acad Sci USA 2003, 100: 6180–6185. 10.1073/pnas.0937087100PubMed CentralView ArticlePubMed
        22. Attal N, Bouhassira D, Gautron M, Vaillant JN, Mitry E, Lepere C, Rougier P, Guirimand F: Thermal hyperalgesia as a marker of oxaliplatin neurotoxicity: a prospective quantified sensory assessment study. Pain 2009, 144: 245–252. 10.1016/j.pain.2009.03.024View ArticlePubMed
        23. Serra J, Sola R, Quiles C, Casanova-Molla J, Pascual V, Bostock H, Valls-Sole J: C-nociceptors sensitized to cold in a patient with small-fiber neuropathy and cold allodynia. Pain 2009, 147: 46–53. 10.1016/j.pain.2009.07.028View ArticlePubMed
        24. Vilholm OJ, Cold S, Rasmussen L, Sindrup SH: Sensory function and pain in a population of patients treated for breast cancer. Acta Anaesthesiol Scand 2009, 53: 800–806. 10.1111/j.1399-6576.2009.01938.xView ArticlePubMed
        25. Choi Y, Yoon YW, Na HS, Kim SH, Chung JM: Behavioral signs of ongoing pain and cold allodynia in a rat model of neuropathic pain. Pain 1994, 59: 369–376. 10.1016/0304-3959(94)90023-XView ArticlePubMed
        26. Egashira N, Hirakawa S, Kawashiri T, Yano T, Ikesue H, Oishi R: Mexiletine reverses oxaliplatin-induced neuropathic pain in rats. J Pharmacol Sci 2010, 112: 473–476. 10.1254/jphs.10012SCView ArticlePubMed
        27. Datta S, Chatterjee K, Kline RH, Wiley RG: Behavioral and anatomical characterization of the bilateral sciatic nerve chronic constriction (bCCI) injury: correlation of anatomic changes and responses to cold stimuli. Mol Pain 2010, 6: 7. 10.1186/1744-8069-6-7PubMed CentralView ArticlePubMed
        28. Caspani O, Zurborg S, Labuz D, Heppenstall PA: The contribution of TRPM8 and TRPA1 channels to cold allodynia and neuropathic pain. PLoS One 2009, 4: e7383. 10.1371/journal.pone.0007383PubMed CentralView ArticlePubMed
        29. Kuhtz-Buschbeck JP, Andresen W, Gobel S, Gilster R, Stick C: Thermoreception and nociception of the skin: a classic paper of Bessou and Perl and analyses of thermal sensitivity during a student laboratory exercise. Adv Physiol Educ 2010, 34: 25–34. 10.1152/advan.00002.2010View ArticlePubMed
        30. Kelly KG, Cook T, Backonja MM: Pain ratings at the thresholds are necessary for interpretation of quantitative sensory testing. Muscle Nerve 2005, 32: 179–184. 10.1002/mus.20355View ArticlePubMed
        31. Davis KD, Pope GE: Noxious cold evokes multiple sensations with distinct time courses. Pain 2002, 98: 179–185. 10.1016/S0304-3959(02)00043-XView ArticlePubMed
        32. Meier PM, Berde CB, DiCanzio J, Zurakowski D, Sethna NF: Quantitative assessment of cutaneous thermal and vibration sensation and thermal pain detection thresholds in healthy children and adolescents. Muscle Nerve 2001, 24: 1339–1345. 10.1002/mus.1153View ArticlePubMed
        33. Harrison JL, Davis KD: Cold-evoked pain varies with skin type and cooling rate: a psychophysical study in humans. Pain 1999, 83: 123–135. 10.1016/S0304-3959(99)00099-8View ArticlePubMed
        34. Chen CC, Rainville P, Bushnell MC: Noxious and innocuous cold discrimination in humans: evidence for separate afferent channels. Pain 1996, 68: 33–43. 10.1016/S0304-3959(96)03180-6View ArticlePubMed
        35. Binder A, Stengel M, Maag R, Wasner G, Schoch R, Moosig F, Schommer B, Baron R: Pain in oxaliplatin-induced neuropathy–sensitisation in the peripheral and central nociceptive system. Eur J Cancer 2007, 43: 2658–2663. 10.1016/j.ejca.2007.07.030View ArticlePubMed
        36. Fleetwood-Walker SM, Proudfoot CW, Garry EM, Allchorne A, Vinuela-Fernandez I, Mitchell R: Cold comfort pharm. Trends Pharmacol Sci 2007, 28: 621–628. 10.1016/j.tips.2007.10.007View ArticlePubMed
        37. Stucky CL, Dubin AE, Jeske NA, Malin SA, McKemy DD, Story GM: Roles of transient receptor potential channels in pain. Brain Res Rev 2009, 60: 2–23. 10.1016/j.brainresrev.2008.12.018PubMed CentralView ArticlePubMed
        38. McKemy DD: How cold is it? TRPM8 and TRPA1 in the molecular logic of cold sensation. Mol Pain 2005, 1: 16. 10.1186/1744-8069-1-16PubMed CentralView ArticlePubMed
        39. Knowlton WM, Bifolck-Fisher A, Bautista DM, McKemy DD: TRPM8, but not TRPA1, is required for neural and behavioral responses to acute noxious cold temperatures and cold-mimetics in vivo. Pain 2010, 150: 340–350. 10.1016/j.pain.2010.05.021PubMed CentralView ArticlePubMed
        40. Dunham JP, Leith JL, Lumb BM, Donaldson LF: Transient receptor potential channel A1 and noxious cold responses in rat cutaneous nociceptors. Neuroscience 2010, 165: 1412–1419. 10.1016/j.neuroscience.2009.11.065PubMed CentralView ArticlePubMed
        41. Kobayashi K, Fukuoka T, Obata K, Yamanaka H, Dai Y, Tokunaga A, Noguchi K: Distinct expression of TRPM8, TRPA1, and TRPV1 mRNAs in rat primary afferent neurons with adelta/c-fibers and colocalization with trk receptors. J Comp Neurol 2005, 493: 596–606. 10.1002/cne.20794View ArticlePubMed
        42. Peier AM, Moqrich A, Hergarden AC, Reeve AJ, Andersson DA, Story GM, Earley TJ, Dragoni I, McIntyre P, Bevan S, et al.: A TRP channel that senses cold stimuli and menthol. Cell 2002, 108: 705–715. 10.1016/S0092-8674(02)00652-9View ArticlePubMed
        43. Macpherson LJ, Hwang SW, Miyamoto T, Dubin AE, Patapoutian A, Story GM: More than cool: promiscuous relationships of menthol and other sensory compounds. Mol Cell Neurosci 2006, 32: 335–343. 10.1016/j.mcn.2006.05.005View ArticlePubMed
        44. Sherkheli MA, Gisselmann G, Vogt-Eisele AK, Goerner JF, Hatt H: Menthol derivative WS-12 selectively activates transient receptor potential melastatin-8 (TRPM8) ion channels. Pak J Pharm Sci 2008, 21: 370–378.
        45. Lu X, Lundstrom L, Bartfai T: Galanin (2–11) binds to GalR3 in transfected cell lines: limitations for pharmacological definition of receptor subtypes. Neuropeptides 2005, 39: 165–167. 10.1016/j.npep.2004.12.013View ArticlePubMed
        46. Holst JJ, Bersani M, Hvidberg A, Knigge U, Christiansen E, Madsbad S, Harling H, Kofod H: On the effects of human galanin in man. Diabetologia 1993, 36: 653–657. 10.1007/BF00404076View ArticlePubMed
        47. Jimenez-Andrade JM, Zhou S, Yamani A, de Ita SV, Castaneda-Hernandez G, Carlton SM: Mechanism by which peripheral galanin increases acute inflammatory pain. Brain Res 2005, 1056: 113–117. 10.1016/j.brainres.2005.07.007View ArticlePubMed
        48. Jimenez-Andrade JM, Zhou S, Du J, Yamani A, Grady JJ, Castaneda-Hernandez G, Carlton SM: Pro-nociceptive role of peripheral galanin in inflammatory pain. Pain 2004, 110: 10–21. 10.1016/j.pain.2004.02.032View ArticlePubMed
        49. Habert-Ortoli E, Amiranoff B, Loquet I, Laburthe M, Mayaux JF: Molecular cloning of a functional human galanin receptor. Proc Natl Acad Sci USA 1994, 91: 9780–9783. 10.1073/pnas.91.21.9780PubMed CentralView ArticlePubMed
        50. Smith KE, Walker MW, Artymyshyn R, Bard J, Borowsky B, Tamm JA, Yao WJ, Vaysse PJ, Branchek TA, Gerald C, et al.: Cloned human and rat galanin GALR3 receptors. Pharmacology and activation of G-protein inwardly rectifying K + channels. J Biol Chem 1998, 273: 23321–23326. 10.1074/jbc.273.36.23321View ArticlePubMed
        51. Wittau N, Grosse R, Kalkbrenner F, Gohla A, Schultz G, Gudermann T: The galanin receptor type 2 initiates multiple signaling pathways in small cell lung cancer cells by coupling to G(q), G(i) and G(12) proteins. Oncogene 2000, 19: 4199–4209. 10.1038/sj.onc.1203777View ArticlePubMed
        52. Bavencoffe A, Gkika D, Kondratskyi A, Beck B, Borowiec AS, Bidaux G, Busserolles J, Eschalier A, Shuba Y, Skryma R, et al.: The transient receptor potential channel TRPM8 is inhibited via the alpha 2A adrenoreceptor signaling pathway. J Biol Chem 2010, 285: 9410–9419. 10.1074/jbc.M109.069377PubMed CentralView ArticlePubMed
        53. Gee MD, Lynn B, Basile S, Pierau FK, Cotsell B: The relationship between axonal spike shape and functional modality in cutaneous C-fibres in the pig and rat. Neuroscience 1999, 90: 509–518. 10.1016/S0306-4522(98)00454-0View ArticlePubMed
        54. Dina OA, Parada CA, Yeh J, Chen X, McCarter GC, Levine JD: Integrin signaling in inflammatory and neuropathic pain in the rat. European Journal Of Neuroscience 2004, 19: 634–642. 10.1111/j.1460-9568.2004.03169.xView ArticlePubMed
        55. Colburn RW, Lubin ML, Stone DJ, Wang Y, Lawrence D, D'Andrea MR, Brandt MR, Liu Y, Flores CM, Qin N: Attenuated cold sensitivity in TRPM8 null mice. Neuron 2007, 54: 379–386. 10.1016/j.neuron.2007.04.017View ArticlePubMed
        56. Leith JL, Koutsikou S, Lumb BM, Apps R: Spinal processing of noxious and innocuous cold information: differential modulation by the periaqueductal gray. J Neurosci 2010, 30: 4933–4942. 10.1523/JNEUROSCI.0122-10.2010View ArticlePubMed
        57. Hulse R, Wynick D, Donaldson LF: Intact cutaneous C fibre afferent properties in mechanical and cold neuropathic allodynia. Eur J Pain 2010, 14: 1–10. 10.1016/j.ejpain.2009.11.002View Article
        58. Hensel H, Zotterman Y: The response of mechanoreceptors to thermal stimulation. J Physiol 1951, 115: 16–24.PubMed CentralView ArticlePubMed
        59. Hensel H, Iggo A, Witt I: A quantitative study of sensitive cutaneous thermoreceptors with C afferent fibres. J Physiol 1960, 153: 113–126.PubMed CentralView ArticlePubMed
        60. Dunham JP, Kelly S, Donaldson LF: Inflammation reduces mechanical thresholds in a population of transient receptor potential channel A1-expressing nociceptors in the rat. European Journal Of Neuroscience 2008, 27: 3151–3160. 10.1111/j.1460-9568.2008.06256.xPubMed CentralView ArticlePubMed
        61. Harling H, Holst JJ: Circulating galanin: origin, metabolism, and pharmacokinetics in anesthetized pigs. Am J Physiol 1992, 262: E52-E57.PubMed
        62. Hulse R, Wynick D, Donaldson LF: Characterization of a novel neuropathic pain model in mice. Neuroreport 2008, 19: 825–829. 10.1097/WNR.0b013e328300ee0aView ArticlePubMed
        63. Walczak JS, Pichette V, Leblond F, Desbiens K, Beaulieu P: Behavioral, pharmacological and molecular characterization of the saphenous nerve partial ligation: a new model of neuropathic pain. Neuroscience 2005, 132: 1093–1102. 10.1016/j.neuroscience.2005.02.010View ArticlePubMed
        64. Donaldson LF, Seckl JR, McQueen DS: A discrete adjuvant-induced monoarthritis in the rat: effects of adjuvant dose. J Neurosci Methods 1993, 49: 5–10. 10.1016/0165-0270(93)90103-XView ArticlePubMed

        Copyright

        © Hulse et al.; licensee BioMed Central Ltd. 2012

        This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

        Advertisement